The operation and implementation of the Kerala government’s order of 21-2-2011 giving exemption to traditional ayurvedic healers of Kerala from acquiring recognized qualification and registration for practicing ayurveda has been stayed by the Kerala High court on April 26.
The court made the judgement on a petition filed by a group of ayurvedic doctors belonging to the Kerala unit of the Ayurvedic Medical Association of India (AMAI). For the AMAI, Advocate P Gopinath Menon appeared in the court.
Besides giving permission to traditional ayurvedic healers, the order of February 21 by the Kerala government had exempted self educated homoeopathic practitioners of Malabar area to practice homoeopathy system without registration and academic qualification.
The high court had earlier stayed the permission given to the fake homoeopaths following a petition submitted by All Kerala Homoeopathic Coordination Council (AKHCC), a movement of qualified homoeopathic practitioners, students, teachers and Medical officers of that system.
The members of AMAI approached the court under Article 226 of the constitution of India requesting to quash the government order issued on February 21 this year. The petition was filed in public interest as well as to protect the professional interests of the Ayurvedic Medical Offices Association.
Office-bearers of AMAI said one of the objectives of the petition was to ensure that quackery bringing disrepute to qualified and authentic medical practitioners be prevented and put an end to ayurvedic system of health care from being misused by quacks in disguise. They said the association has definite knowledge that a large number of bogus practitioners continued to defraud the public by masquerading themselves as Ayurveda doctors and thereby cheating the public.
The order said that the unqualified and self-learnt people hailing from traditional healers’ family of Palakkad, Malappuram, Kozhikode, Wayanad, Kannur and Kasargod districts and were in the practising field for a continuous period of 20 years prior to 01-01-2011,could continue their practice in the concerned system by virtue of their hereditary.
The government had issued the order based on section 38 of the Travancore-Cochin Medical Practitioners Act 1953. The government had also exempted these traditional practitioners from the requirement of recognized qualification and registration.
Members of AMAI said the government order is against the provisions of the central council act. According to the association, the provisions of the TCMP Act has never been extended to the Malabar area of the state of Kerala , which was part of Madras province of the British India, prior to the formation of Kerala in 1956. It was the Madras Medical Registration Act 1914 that regulated the practice of medicine in the Madras province.
Thursday, 28 April 2011
Sunday, 24 April 2011
Ayurveda in Allopathy - in 20 Hrs ?
Maharashtra to include Ayurveda as part of MBBS syllabus
Our Bureau, Mumbai
Saturday, April 23, 2011, 08:00 Hrs [IST]
The Maharashtra University of Health Science (MUHS) will soon constitute an expert committee to discuss the new syllabus for the MBBS students for the coming academic year as it has been decided to include basic Ayurveda as part of MBBS syllabus in the medical colleges in the state.
A decision to include Ayurveda in MBBS syllabus was taken following recommendations from the Ayush department. There are 34 private and government medical colleges in the state. Their syllabus comes under the purview of the MUHS. According to the Ayush recommendations, every medical college should reserve at least 20 hours to teach ayurvedic science in MBBS classes.
Dr Arun Jamkar, vice chancellor, MUHS said “As per the suggestions made by Dept of Ayush we are meeting up to form a committee to implement these directives and to discuss the new syllabus for the medical students for the coming year.” He further informed that Maharashtra will be the first state for implementing such directives.
Dr Arun Jamkar, vice chancellor, MUHS said “We are meeting soon to form a committee to implement these directives and to discuss the new syllabus for the medical students for the coming year.”
Dr Vijay Magar, associate professor at the RA Podar Ayurvedic College and Hospital, Mumbai said “Ayurveda is an ancient medicine and the students are more interested in learning modern medicine. For this it is a nice move as modern medicine doctors should be familiar with ancient medicine and its treatment methodology. Every person should know about Ayurveda. Instead of devoting so much time for a course, we can have atleast one lecture every week. Like for conducting research in herbal products there are separate institutes.”
Dr Jamkar informed that as most of the universities across the world has been teaching the ancient medicine of their respective cultures. For instance, modern medicine doctors in China get lessons in Chinese medicine. “Finally we too are introducing the study of our ancient medicine. We are proud that ours will be the first state in the country to implement the Ayush directives”, he added.
MUHS ensures in proper and systematic instruction, teaching, training and research in modern medicine and Indian systems of medicine in the state of Maharashtra, and to have balanced growth in the medical sciences. They are taking initiative to implement this decision to attract more MBBS students to take up Ayurveda as the major subject to practice and to research on the same.
Our Bureau, Mumbai
Saturday, April 23, 2011, 08:00 Hrs [IST]
The Maharashtra University of Health Science (MUHS) will soon constitute an expert committee to discuss the new syllabus for the MBBS students for the coming academic year as it has been decided to include basic Ayurveda as part of MBBS syllabus in the medical colleges in the state.
A decision to include Ayurveda in MBBS syllabus was taken following recommendations from the Ayush department. There are 34 private and government medical colleges in the state. Their syllabus comes under the purview of the MUHS. According to the Ayush recommendations, every medical college should reserve at least 20 hours to teach ayurvedic science in MBBS classes.
Dr Arun Jamkar, vice chancellor, MUHS said “As per the suggestions made by Dept of Ayush we are meeting up to form a committee to implement these directives and to discuss the new syllabus for the medical students for the coming year.” He further informed that Maharashtra will be the first state for implementing such directives.
Dr Arun Jamkar, vice chancellor, MUHS said “We are meeting soon to form a committee to implement these directives and to discuss the new syllabus for the medical students for the coming year.”
Dr Vijay Magar, associate professor at the RA Podar Ayurvedic College and Hospital, Mumbai said “Ayurveda is an ancient medicine and the students are more interested in learning modern medicine. For this it is a nice move as modern medicine doctors should be familiar with ancient medicine and its treatment methodology. Every person should know about Ayurveda. Instead of devoting so much time for a course, we can have atleast one lecture every week. Like for conducting research in herbal products there are separate institutes.”
Dr Jamkar informed that as most of the universities across the world has been teaching the ancient medicine of their respective cultures. For instance, modern medicine doctors in China get lessons in Chinese medicine. “Finally we too are introducing the study of our ancient medicine. We are proud that ours will be the first state in the country to implement the Ayush directives”, he added.
MUHS ensures in proper and systematic instruction, teaching, training and research in modern medicine and Indian systems of medicine in the state of Maharashtra, and to have balanced growth in the medical sciences. They are taking initiative to implement this decision to attract more MBBS students to take up Ayurveda as the major subject to practice and to research on the same.
Monday, 11 April 2011
Friday, 8 April 2011
Scientific Study of Anti cancer drugs used by Vaidya by CCRAS and other Institutes of repute treating cancer
CCRAS approves 2 cancer drugs for trials, open to examine more drug claims
Central Council for Research in Ayurveda and Siddha (CCRAS) has in principle approved a couple of Ayurvedic drugs used by some prominent practitioners to successfully treat the cancer patients and is planning to launch the multi-centric clinical trials. The Council also disclosed that it was open to examine other such claims with regard to ongoing successful treatment of critical diseases by Ayurvedic practitioners.
On the recommendation of the Scientific Advisory Committee (Ayurveda), the CCRAS has initiated the study of ‘CARCTOL’ a proprietary medicine of Vaid Nand Lal Tiwari of Jaipur supposed to have anti-cancer properties. For verifying the therapeutic claim, standardization work has been completed by the Council. Safety and toxicity studies have also been completed, sources said.
“CARCTOL has also been subjected to in-vitro study at Advanced Cancer Research Centre of TATA, Mumbai against 14 types of human cancer cells out of which it was found effective against pancreatic and lung cancer. It was placed on record that CARCTOL is being used for treatment of cancer patients both in the country and abroad. After preparation of dossiers, multi-centric clinical trials will be conducted,” sources in the Council said.
Pre-clinical study of ‘Cancer Gaza Kesari’ a proprietary drug of Vaid Krishan Gopal of Ajmer has also been conducted by the Council in collaboration with Veterinary College, Chennai. The study revealed that the drug significantly reduced the mammary tumour incidence, latency, frequency, rate of growth and malignancy. It was also subjected to in-vitro study against 14 types of human cancer cell line, out of which it has shown to be of effective against pancreatic and lung cancer, Council official said.
A pilot project was sanctioned by the Ministry in 1996 to study the effects of metal based formulations prepared by Vaid Balendu Prakash of Dehradun in the treatment of Acute pro-myllolic Leukaemia. The drug was patented jointly by the Council with Germany. Vaid Balendu Prakash has been treating cancer patients with the drug and the patent was in fact for the process. “So far only a pilot study of 21 patients has been conducted by the Council. Multi- cultural clinical trials of the drug were to be undertaken which would take four years,” sources said.
In another effort to develop ayurvedic drug for cancer, clinical trials of 'AYUSH QOL – 2C' developed by Central Council for Research in Ayurveda and Siddha (CCRAS) for improvement of quality of life of those receiving chemotherapy/radio-therapy, have been initiated at St. Johns medical college, Bangalore and at the All India Institute of Medical Science, New Delhi. The ethical approval and release of funds for trials at AIIMS have been completed and the registration of patients will begin shortly. Simultaneously, 10 patients have been enrolled for study at St. Johns Medical College.
“Whenever any claim is submitted to Council, the same is examined and put before Scientific Advisory Committee to carry out scientific validation. In this context, two claims on cancer have been subjected to pre-clinical studies based on which clinical trial will be carried out as per lead. If any drug is finally marketed, the benefit will be shared by Council and the claimant,” sources said about possibility of examining claims by practitioners.
Central Council for Research in Ayurveda and Siddha (CCRAS) has in principle approved a couple of Ayurvedic drugs used by some prominent practitioners to successfully treat the cancer patients and is planning to launch the multi-centric clinical trials. The Council also disclosed that it was open to examine other such claims with regard to ongoing successful treatment of critical diseases by Ayurvedic practitioners.
On the recommendation of the Scientific Advisory Committee (Ayurveda), the CCRAS has initiated the study of ‘CARCTOL’ a proprietary medicine of Vaid Nand Lal Tiwari of Jaipur supposed to have anti-cancer properties. For verifying the therapeutic claim, standardization work has been completed by the Council. Safety and toxicity studies have also been completed, sources said.
“CARCTOL has also been subjected to in-vitro study at Advanced Cancer Research Centre of TATA, Mumbai against 14 types of human cancer cells out of which it was found effective against pancreatic and lung cancer. It was placed on record that CARCTOL is being used for treatment of cancer patients both in the country and abroad. After preparation of dossiers, multi-centric clinical trials will be conducted,” sources in the Council said.
Pre-clinical study of ‘Cancer Gaza Kesari’ a proprietary drug of Vaid Krishan Gopal of Ajmer has also been conducted by the Council in collaboration with Veterinary College, Chennai. The study revealed that the drug significantly reduced the mammary tumour incidence, latency, frequency, rate of growth and malignancy. It was also subjected to in-vitro study against 14 types of human cancer cell line, out of which it has shown to be of effective against pancreatic and lung cancer, Council official said.
A pilot project was sanctioned by the Ministry in 1996 to study the effects of metal based formulations prepared by Vaid Balendu Prakash of Dehradun in the treatment of Acute pro-myllolic Leukaemia. The drug was patented jointly by the Council with Germany. Vaid Balendu Prakash has been treating cancer patients with the drug and the patent was in fact for the process. “So far only a pilot study of 21 patients has been conducted by the Council. Multi- cultural clinical trials of the drug were to be undertaken which would take four years,” sources said.
In another effort to develop ayurvedic drug for cancer, clinical trials of 'AYUSH QOL – 2C' developed by Central Council for Research in Ayurveda and Siddha (CCRAS) for improvement of quality of life of those receiving chemotherapy/radio-therapy, have been initiated at St. Johns medical college, Bangalore and at the All India Institute of Medical Science, New Delhi. The ethical approval and release of funds for trials at AIIMS have been completed and the registration of patients will begin shortly. Simultaneously, 10 patients have been enrolled for study at St. Johns Medical College.
“Whenever any claim is submitted to Council, the same is examined and put before Scientific Advisory Committee to carry out scientific validation. In this context, two claims on cancer have been subjected to pre-clinical studies based on which clinical trial will be carried out as per lead. If any drug is finally marketed, the benefit will be shared by Council and the claimant,” sources said about possibility of examining claims by practitioners.
Wednesday, 6 April 2011
Marma at College of Ayurveda in USA ? What about Indian Colleges of Ayurveda in mass ?
An Ancient Art that Balances Body and Mind: Marma Point Training Offered this Summer by the California College of Ayurveda
Tuesday, April 5, 2011
________________________________________
Los Angeles, CA (Vocus/PRWEB) April 05, 2011
Marma points are 107 energetic body points that allow access to the body, mind and consciousness. Marmas are commonly used in Indian martial arts and are used in Ayurvedic Medicine to bring about healing. The California College of Ayurveda announces its Marma Therapy course this summer as part of the pancha karma training intensives.
Marma therapy can be used as part of a panchakarma program. Pancha Karma (Panchakarma) is the Ayurvedic art of detoxification, purification, and rejuvenation, and is a powerful way to address the root cause of disease and has been used for thousands of years as a method for staying healthy, young, and vital.
Marmas are related to our mind and our emotions. In the words of Dr. David Frawley, "marmas can held emotions such as fear (vata), anger (pitta) or attachment (kapha), as well as the gunas or primary qualities of sattva (calm), rajas (aggression) and tamas (inertia)."
The California College of Ayurveda offers complete training in Ayurvedic marma therapy as part of its panchakarma and Ayurvedic training intensives. During the program, students will learn the history, classifications, theory and locations, and the effect of each point on the doshas and organs of the body.
Students will learn how to interact with each marma point using massage, essential oil application and pranic healing (Ayurvedic energy work) to restore balance to the body and mind. Specific protocols will be taught for bringing healing to different organ systems.
Established in 1995, the California College of Ayurveda is the longest running, State-approved college offering professional training program for the study of Ayurvedic Medicine in the West. For more information, please visit Ayurvedacollege.com or call (530) 478 9100
Tuesday, April 5, 2011
________________________________________
Los Angeles, CA (Vocus/PRWEB) April 05, 2011
Marma points are 107 energetic body points that allow access to the body, mind and consciousness. Marmas are commonly used in Indian martial arts and are used in Ayurvedic Medicine to bring about healing. The California College of Ayurveda announces its Marma Therapy course this summer as part of the pancha karma training intensives.
Marma therapy can be used as part of a panchakarma program. Pancha Karma (Panchakarma) is the Ayurvedic art of detoxification, purification, and rejuvenation, and is a powerful way to address the root cause of disease and has been used for thousands of years as a method for staying healthy, young, and vital.
Marmas are related to our mind and our emotions. In the words of Dr. David Frawley, "marmas can held emotions such as fear (vata), anger (pitta) or attachment (kapha), as well as the gunas or primary qualities of sattva (calm), rajas (aggression) and tamas (inertia)."
The California College of Ayurveda offers complete training in Ayurvedic marma therapy as part of its panchakarma and Ayurvedic training intensives. During the program, students will learn the history, classifications, theory and locations, and the effect of each point on the doshas and organs of the body.
Students will learn how to interact with each marma point using massage, essential oil application and pranic healing (Ayurvedic energy work) to restore balance to the body and mind. Specific protocols will be taught for bringing healing to different organ systems.
Established in 1995, the California College of Ayurveda is the longest running, State-approved college offering professional training program for the study of Ayurvedic Medicine in the West. For more information, please visit Ayurvedacollege.com or call (530) 478 9100
Extremely needed action from regulatary authorities - Congrats to every shareholder responsible for action againt Musali Xtra power -Success of Alertness
Kerala govt bans production and sale of herbal aphrodisiac, ‘Musli Power Xtra’
Peethaambaran Kunnathoor, Chennai
Tuesday, April 05, 2011, 11:40 Hrs [IST]
The Government of Kerala has banned the production and sale of the popular herbal aphrodisiac, ‘Musli Power Xtra’, being produced and marketed by Kunnath Pharmaceuticals, for violation of the provision of Rule 106 of the Drugs and Cosmetics Rules, 1945.
Rule 106 specifies that no drug may purport or claim to prevent or cure or may convey to the intending user thereof any idea that it may prevent or cure, one or more of the diseases or ailments specified in Schedule J. This Schedule includes, among other diseases, sexual impotency also. Kunnath Pharma has given wide publicity for their aphrodisiac product in print and visual media.
Government took the crucial decision to prohibit the drug under section 33 EEC of the Drugs & Cosmetics Act which empowers a state government to ban a herbal drug in certain cases, sources from the health ministry said.
The state government will also file a prosecution case against the Ernakulam based manufacturing company under Misuse and Improper use of Emblem Act as in the advertisement of the herbal product the company has reportedly used a picture that the managing director receiving an award from the President of India, sources from the health ministry told Pharmabiz.
Later while speaking to this reporter, KC Abraham, the MD of Kunnath Pharma said he was called to New Delhi previously by Rashtrapathi Bhavan sources to seek explanation from him for the use of the picture in the advertisement, and he assured them not to repeat it in future. He added that so far he did not get any information from the Kerala government banning his herbal drug.
According to section 33 EEC, from the date on which a state government notifies the prohibition in the official gazette, no person, either by himself or any other person on his behalf, can manufacture the product for sale or for distribution. Sources in the health ministry said government has banned the drug on April 2 and the notification has already been sent for official publication in the gazette.
The state Ayurveda drugs controller, N Vimala, said their department has received the prohibition order from the government and she would intimate it to Kunnath Pharmaceuticals today. The DC said the company is facing four cases in various courts with charges under Spurious Drugs Act and violation of Drugs and Magic Remedies (Objectionable Advertisement) Act,1954.
DMROA Act has been enacted with a view to control the advertisements of drugs in certain cases and to prohibit the advertisements for certain purposes of remedies alleged to possess magic qualities. Schedule J of the D&C Rules 1945 also deals with objectionable advertisements. The ADMROA Act also specifies the prohibition of advertisement for certain drugs, especially in the category of drugs described as aphrodisiac.
Besides the cases filed by the drugs control department, a Kochi based social organisation, ‘People’s Union for Civil Liberties (PUCL) has also filed a writ petition with the High Court of Kerala against Kunnath Pharmaceuticals for violation of DMROA Act 1954.
Earlier the drug authorities of Kerala had challenged the efficacy of Musli Power Xtra which claimed it had the potential to boost sexual power in both men and women and a reliable remedy for infertility related problems. Through wide advertisement in print and visual media, the company has been enjoying extensive sales all over the country and outside.
Sources in the health department said in the company’s website they have given obnoxious publicity to attract young men and women by giving the impression that the drug would increase the sexual passion. Further it has published fake feedbacks as positive experiences of consumers irrespective of their age.
Six months ago, the Delhi Institute of Pharmaceutical Sciences & Research (DIPS&R) had found that among five ayurvedic formulations marketed in the country by various manufacturing companies, Musli Power Xtra was adulterated and mixed with Tadalafil (phosphodies).
In one of the cases filed against the company, the charge was for change of ingredients. Initially, in the approval granted for production of Musli Power Xtra formulation, the main ingredient indicated was the seed of ‘Nilappana’ (Curculigo Orchioides), but the company made the drug with the extracts of Safed Musli (Chlorophytum Borivilianum) for which no licences had been given then. But later, Safed Musli was included in the pharmacopoeia and subsequently the company secured a separate licence as it is the main ingredient.
Peethaambaran Kunnathoor, Chennai
Tuesday, April 05, 2011, 11:40 Hrs [IST]
The Government of Kerala has banned the production and sale of the popular herbal aphrodisiac, ‘Musli Power Xtra’, being produced and marketed by Kunnath Pharmaceuticals, for violation of the provision of Rule 106 of the Drugs and Cosmetics Rules, 1945.
Rule 106 specifies that no drug may purport or claim to prevent or cure or may convey to the intending user thereof any idea that it may prevent or cure, one or more of the diseases or ailments specified in Schedule J. This Schedule includes, among other diseases, sexual impotency also. Kunnath Pharma has given wide publicity for their aphrodisiac product in print and visual media.
Government took the crucial decision to prohibit the drug under section 33 EEC of the Drugs & Cosmetics Act which empowers a state government to ban a herbal drug in certain cases, sources from the health ministry said.
The state government will also file a prosecution case against the Ernakulam based manufacturing company under Misuse and Improper use of Emblem Act as in the advertisement of the herbal product the company has reportedly used a picture that the managing director receiving an award from the President of India, sources from the health ministry told Pharmabiz.
Later while speaking to this reporter, KC Abraham, the MD of Kunnath Pharma said he was called to New Delhi previously by Rashtrapathi Bhavan sources to seek explanation from him for the use of the picture in the advertisement, and he assured them not to repeat it in future. He added that so far he did not get any information from the Kerala government banning his herbal drug.
According to section 33 EEC, from the date on which a state government notifies the prohibition in the official gazette, no person, either by himself or any other person on his behalf, can manufacture the product for sale or for distribution. Sources in the health ministry said government has banned the drug on April 2 and the notification has already been sent for official publication in the gazette.
The state Ayurveda drugs controller, N Vimala, said their department has received the prohibition order from the government and she would intimate it to Kunnath Pharmaceuticals today. The DC said the company is facing four cases in various courts with charges under Spurious Drugs Act and violation of Drugs and Magic Remedies (Objectionable Advertisement) Act,1954.
DMROA Act has been enacted with a view to control the advertisements of drugs in certain cases and to prohibit the advertisements for certain purposes of remedies alleged to possess magic qualities. Schedule J of the D&C Rules 1945 also deals with objectionable advertisements. The ADMROA Act also specifies the prohibition of advertisement for certain drugs, especially in the category of drugs described as aphrodisiac.
Besides the cases filed by the drugs control department, a Kochi based social organisation, ‘People’s Union for Civil Liberties (PUCL) has also filed a writ petition with the High Court of Kerala against Kunnath Pharmaceuticals for violation of DMROA Act 1954.
Earlier the drug authorities of Kerala had challenged the efficacy of Musli Power Xtra which claimed it had the potential to boost sexual power in both men and women and a reliable remedy for infertility related problems. Through wide advertisement in print and visual media, the company has been enjoying extensive sales all over the country and outside.
Sources in the health department said in the company’s website they have given obnoxious publicity to attract young men and women by giving the impression that the drug would increase the sexual passion. Further it has published fake feedbacks as positive experiences of consumers irrespective of their age.
Six months ago, the Delhi Institute of Pharmaceutical Sciences & Research (DIPS&R) had found that among five ayurvedic formulations marketed in the country by various manufacturing companies, Musli Power Xtra was adulterated and mixed with Tadalafil (phosphodies).
In one of the cases filed against the company, the charge was for change of ingredients. Initially, in the approval granted for production of Musli Power Xtra formulation, the main ingredient indicated was the seed of ‘Nilappana’ (Curculigo Orchioides), but the company made the drug with the extracts of Safed Musli (Chlorophytum Borivilianum) for which no licences had been given then. But later, Safed Musli was included in the pharmacopoeia and subsequently the company secured a separate licence as it is the main ingredient.
Subscribe to:
Posts (Atom)